Apiam Animal Health Yönetim

Yönetim kriter kontrolleri 3/4

Apiam Animal Health CEO'su Chris Richards, Nov2015 tarihinde atandı, in görev süresi 9.17 yıldır. şirketin hisselerinin 22.79% doğrudan sahiptir ve bu hisselerin değeri A$ 16.85M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.2 yıl ve 9.2 yıldır.

Anahtar bilgiler

Chris Richards

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	9.2yrs
CEO sahipliği	22.8%
Yönetim ortalama görev süresi	4.2yrs
Yönetim Kurulu ortalama görev süresi	9.2yrs

Son yönetim güncellemeleri

Recent updates

There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price

Aug 08

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Feb 24

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

Oct 12

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Sep 02

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Feb 28

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

Nov 18

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Mar 12

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

Feb 25

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Feb 08

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jan 18

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

Dec 28

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price

Dec 11

Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?

Nov 24

CEO Tazminat Analizi

Chris Richards'un ücretlendirmesi Apiam Animal Health'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	AU$5m
Mar 31 2024	n/a	n/a	AU$4m
Dec 31 2023	n/a	n/a	AU$3m
Sep 30 2023	n/a	n/a	AU$2m
Jun 30 2023	AU$596k	AU$432k	AU$2m
Mar 31 2023	n/a	n/a	AU$4m
Dec 31 2022	n/a	n/a	AU$6m
Sep 30 2022	n/a	n/a	AU$5m
Jun 30 2022	AU$505k	AU$368k	AU$5m
Mar 31 2022	n/a	n/a	AU$4m
Dec 31 2021	n/a	n/a	AU$4m
Sep 30 2021	n/a	n/a	AU$5m
Jun 30 2021	AU$455k	AU$361k	AU$5m
Mar 31 2021	n/a	n/a	AU$5m
Dec 31 2020	n/a	n/a	AU$5m
Sep 30 2020	n/a	n/a	AU$5m
Jun 30 2020	AU$401k	AU$355k	AU$4m
Mar 31 2020	n/a	n/a	AU$4m
Dec 31 2019	n/a	n/a	AU$3m
Sep 30 2019	n/a	n/a	AU$3m
Jun 30 2019	AU$389k	AU$350k	AU$3m
Mar 31 2019	n/a	n/a	AU$3m
Dec 31 2018	n/a	n/a	AU$3m
Sep 30 2018	n/a	n/a	AU$3m
Jun 30 2018	AU$396k	AU$350k	AU$3m

Tazminat ve Piyasa: Chris şirketinin toplam tazminatının Australian pazarındaki benzer büyüklükteki şirketlerle karşılaştırıldığında makul olup olmadığını tespit etmek için yeterli veri yok.

Tazminat ve Kazançlar: Chris 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Chris Richards

9.2yrs

Görev süresi

AU$595,673

Tazminat

Dr. Christopher Irwin Richards, also known as Chris, BSc, BVSc, MAICD, has been Managing Director of Apiam Animal Health Limited since November 1, 2015. Dr. Richards founded Chris Richards & Associates in...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Christopher Richards	MD & Executive Director	9.2yrs	AU$595.67k	22.79% A$ 16.8m
Matthew White	Chief Financial Officer	no data	AU$347.51k	0.25% A$ 187.0k
Renee Waters	Chief People Officer	no data	AU$258.44k	0.093% A$ 68.4k
Duncan Runciman	Chief Veterinary Officer	less than a year	Veri yok	0.60% A$ 446.0k
Eryl Baron	Company Secretary	4.2yrs	Veri yok	Veri yok

4.2yrs

Ortalama Görev Süresi

Deneyimli Yönetim: AHX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Christopher Richards	MD & Executive Director	9.8yrs	AU$595.67k	22.79% A$ 16.8m
Bruce Dixon	Independent Non-Executive Director	less than a year	Veri yok	Veri yok
Andrew Vizard	Independent Non-Executive Chairman	9.2yrs	AU$140.00k	0.19% A$ 143.1k
Evonne Collier	Independent Non-Executive Director	2.3yrs	AU$52.50k	Veri yok
Richard Dennis	Independent Non-Executive Director	9.2yrs	AU$80.00k	0.0069% A$ 5.1k

9.2yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: AHX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9.2 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2025/01/31 18:00
Gün Sonu Hisse Fiyatı	2025/01/31 00:00
Kazançlar	2024/06/30
Yıllık Kazançlar	2024/06/30

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Apiam Animal Health Limited 3 Bu analistlerden 0, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Russell Wright	Barclay Pearce Capital Pty Limited
Louis Bannon	CCZ Equities Pty Limited
Jonathon Higgins	Shaw and Partners Limited

Apiam Animal Health Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Apiam Animal Health Limited, Annual General Meeting, Nov 21, 2024

Apiam Animal Health Limited Announces Board Changes

MD & Executive Director recently bought AU$596k worth of stock

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

MD & Executive Director recently bought AU$134k worth of stock

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

Recent updates

Apiam Animal Health Limited, Annual General Meeting, Nov 21, 2024

An undisclosed buyer terminated the acquisition of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited Announces Board Changes

Full year 2024 earnings released: EPS: AU$0.028 (vs AU$0.013 in FY 2023)

Apiam Animal Health Limited to Report Fiscal Year 2024 Results on Aug 23, 2024

There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price

MD & Executive Director recently bought AU$596k worth of stock

Upcoming dividend of AU$0.01 per share

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

MD & Executive Director recently bought AU$134k worth of stock

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Financial data availability

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

Consensus EPS estimates fall by 17%

Price target decreased by 8.0% to AU$0.86

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Apiam Animal Health Limited to Report First Half, 2023 Results on Feb 24, 2023

Apiam Animal Health Limited (ASX:AHX) acquired Hunter Equine Centre Pty Ltd for AUD 6.5 million.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harradine and Associates for AUD 2.6 million.

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

MD & Executive Director recently sold AU$354k worth of stock

Price target increased to AU$1.13

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Apiam Animal Health Limited to Report Fiscal Year 2022 Results on Aug 29, 2022

Consensus forecasts updated

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire assets of Victorian Equine Group and Romsey Veterinary Surgery for AUD 13.75 million.

Insufficient new directors

Upcoming dividend of AU$0.012 per share

Consensus forecasts updated

First half 2022 earnings: EPS misses analyst expectations

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Period Ended December 31, 2021, Payable on April 20, 2022

Apiam Animal Health Limited to Report First Half, 2022 Results on Feb 25, 2022

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Fraser Coast Veterinary Services.

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

MD & Executive Director recently bought AU$96k worth of stock

Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Harbour City Veterinary Surgery.

Insufficient new directors

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Full year 2021 earnings released: EPS AU$0.042 (vs AU$0.037 in FY 2020)

Price target increased to AU$0.85

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harbour City Veterinary Surgery for AUD 2.8 million.

Apiam Animal Health Limited (ASX: AHX) acquired Assets of Golden Plains Animal Hospital.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire The Scenic Rim for AUD 16 million.

A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Samford Valley Veterinary Hospital.

Apiam Animal Health Limited (ASX:AHX) acquired Clermont Veterinary Surgery.

MD & Executive Director recently bought AU$252k worth of stock

With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting

Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Upcoming Dividend of AU$0.012 Per Share

New 90-day high: AU$0.74

Analysts update estimates

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

First half 2021 earnings released: EPS AU$0.022 (vs AU$0.015 in 1H 2020)

Apiam Animal Health Limited to Report First Half, 2021 Results on Feb 24, 2021

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

New 90-day low: AU$0.57

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

New 90-day low: AU$0.60

Price target lowered to AU$0.59